Key facts
- It has raised $49.9M; the latest was Accelerator/Incubator in Jul 2024.
- Notable investors include Innovate UK, Transpose Platform Management, Entrepreneurs First, Charles Songhurst, Phoenix Court — 16 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 16 names
- ·Watchlist + deal alerts for Accurx
- ·The full record, as it builds
Funding rounds
No funding rounds for Accurx are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Accurx
Developer of a healthcare communication platform designed to communicate with patients. The company's platform offers appointment booking, solving patient questionnaires, online consultations, video consultations, and more, enabling medical professionals to easily communicate with their patients.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2016
- Employees
- 250
- Website
- accurx.com/
- Ownership
- Privately Held (backing)
Accurx doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Accurx shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Accurx in its N-PORT filings yet. We sweep new filings monthly.